Philippines - English - FDA (Food And Drug Administration)

virbac philippines inc.; distributor: virbac philippines inc. - inactivated bordetella bronchiseptica , pasteurella multocida , actinobacillus pleuropneumoniae , mycoplasma hyopneumoniae , streptococcus suis , haemophilus parasuis vaccine (vet.) - suspension for injection (im) - formulation: each 1 ml (dose) contains: bordetella bronchiseptica -1 od bordetella bronchiseptica (dnt)-200 ug/ml pasteurella multocida (type a and d)-i od p. multocida type a (omp)-30 ug/ml actinobacillus pleuropneumoniae (serotype 2 and 5)-1 od p. multocida type d (dnt)-200 ug/ml mycoplasma hvopneumoniae-0.12 od a. pleuropneumoniae serotype 2 and 5 (toxin) 10 ug/ml streptococcus suis (type 2)-0.45 od haemophilus parasuis (serotype 1, 4 and 5)-0.45 od od - optical density at 410 nm absorbance (elisa) dnt – dermonecrotic toxin omp - outer membrane protein

Philippines - English - FDA (Food And Drug Administration)

hipra philippines inc.; distributor: hipra philippines inc. - inactivated bordetella bronchiseptica , pasteurella multocida toxin vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: bordetella bronchiseptica (strain 833 cer).....................2 x 100 corresponding to 9.8 bbcc pasteurella multocida toxin (type d)...........................110 ug inducing >i med63 bordetella bronchiseptica cell count (bbcc) murine effective dose 63 (med)

Philippines - English - FDA (Food And Drug Administration)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - inactivated bordetella bronchiseptica , pasteurella multocida vaccine (vet.) : - suspension for injection (im) - formulation: each 2 ml (dose) contains: bordetella bronchiseptica (372cn strain) ...... ......... >0.9 sa unit pasteurella multocida (m17 strain) ...................... >0.9 elisa unit pasteurella multocida (m17 strain) toxoid.............. >1 elisa unit sa - seroagglutinating unit to obtain 1 log 10 seroagglutinating antibodies in laboratory animals elisa - enzyme-linked immunosorbent assay unit to obtain 1 log10 seroagglutinating antibodies in laboratory animals

Philippines - English - FDA (Food And Drug Administration)

nobel vet, inc.; distributor: nobel vet, inc. - inactivated bordetella bronchiseptica , pasteurella multocida , actinobacillus pleuropneumoniae , glaesserella parasuis , mesomycoplasma hyopneumoniae vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: bordetella bronchiseptica (bb1 strain) ... 21.5 x 1010 cfu bordetella bronchiseptica toxoid ....... .............. 500 ug pasteurella multocida, type a and d..... ....... 21.5 x 1010 cfu pasteurella multocida type d toxoid ............... 500 ug actinobacillus pleuropneumoniae, type 2 and 5 ................. ..... 21 x 1010 cfu actinobacillus pleuropneumoniae, type 2 and 5 toxoid .......... ................ 100 ug glaesserella parasuis, type 4 and 5 ........... ........ 24 x 10°cfu mesomycoplasma hyopneumoniae (j101 strain) .............. ........ 22 x 108 cfu cfu - colony forming unit

Philippines - English - FDA (Food And Drug Administration)

broadchem philippines biopharma corporation - inactivated actinobacillus pleuropneumoniae , bordetella bronchiseptica , pasteurella multocida , actinobacillus pleuropneumoniae toxoid vaccine (vet.) - emulsion for injection (im) - formulation: each ml (dose) contains: actinobacillus pleuropneumoniae serotype 2 and 9 …………………..≥ 1 rp bordetella bronchiseptica serotype 9 …………………..≥ 1 rp pasteurella multocida serotype 625/a and 115/d…………………..≥ 1 rp actinobacillus pleuropneumoniae (apx i, ii and iii toxin)…………………..≥ 1 rp rp relative potency

Philippines - English - FDA (Food And Drug Administration)

zoetis philippines inc.; distributor: zoetis philippines inc. - inactivated bordetella bronchiseptica , pasteurella multocidạ vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: bordetella bronchiseptica (2-9 nadl strain)................ >1.8 ou pasteurella multocida (type d) (strain 8).................. >4.0 cellsou pasteurella multocida (type d) (strain 8)............... > 175 toxoid ru . ru-relative units ou-opacity units

United Kingdom - English - VMD (Veterinary Medicines Directorate)

intervet uk ltd - bordetella bronchiseptica, pasteurella multocida -

United Kingdom - English - VMD (Veterinary Medicines Directorate)

msd animal health uk limited - bordetella bronchiseptica, pasteurella multocida - suspension for injection - inactivated bacterial vaccine - pigs

European Union - English - EMA (European Medicines Agency)

laboratorios hipra s.a. - inactivated bordetella bronchiseptica, strain 833cer / recombinant type-d pasteurella-multocida toxin (pmtr) - immunologicals - pigs (gilts and sows) - for the passive protection of piglets via colostrum after active immunisation of sows and gilts to reduce the clinical signs and lesions of progressive and non-progressive atrophic rhinitis, as well as to reduce weight loss associated with bordetella-bronchiseptica and pasteurella-multocida infections during the fattening period. challenge studies have demonstrated that passive immunity lasts until piglets are six weeks of age while in clinical field trials, the beneficial effects of vaccination (reduction in nasal lesion score and weight loss) are observed until slaughter.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - bordetella bronchiseptica killed vaccine - misc. vaccines or anti sera - bordetella bronchiseptica killed vaccine vaccine-microbial active 0.0 p - immunotherapy - dog | bitch | castrate | puppy - bordetella bronchiseptica | canine cough syndrome | infectious tracheobronchitis